Autor: "Rockstroh, Jürgen" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study.
Autorzy:: Carson JM; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Barbieri S; The Centre for Big Data Research in Health, UNSW Sydney, Sydney, New South Wales, Australia.
Cunningham E; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Mao E; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
van der Valk M; Division of Infectious Diseases, Amsterdam Infection and Immunity Institute, University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.; Stichting HIV Monitoring, Amsterdam, The Netherlands.
Rockstroh JK; University Hospital Bonn, Bonn, Germany.
Hellard M; Burnet Institute, Melbourne, Victoria, Australia.; The Alfred Hospital, Melbourne, Victoria, Australia.
Kim A; Massachusetts General Hospital, Boston, Massachusetts, USA.
Bhagani S; Royal Free Hospital, London, UK.
Feld JJ; Toronto Centre for Liver Diseases, Toronto General Hospital, Toronto, Ontario, Canada.
Gane E; Auckland City Hospital, Auckland, New Zealand.
Thurnheer MC; Department of Infectious Diseases, Bern Inselspital, Bern, Switzerland.
Bruneau J; Research Center, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
Tu E; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Dore GJ; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Matthews GV; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Martinello M; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.; Pokaż więcej
Corporate Authors:: REACT study group; Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2023 Sep; Vol. 26 (9), pp. e26168.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: HIV Infections*
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Opioid-Related Disorders*
Male ; Humans ; Hepacivirus ; Reinfection ; Risk-Taking

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
Autorzy:: Nikolaichuk M; Department of the Infectious Diseases, Dnipro State Medical University, Dnipro, Ukraine.
Mocroft A; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, UCL, London, UK.
Wandeler G; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Szlavik J; South-Pest Hospital Centre-National Institute for Infectology and Haematology, Budapest, Hungary.
Gottfredsson M; Landspitali University Hospital, Reykjavik, Iceland.; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Reikvam DH; Department of Infectious diseases, Oslo University Hospital, Oslo, Norway.
Svedhem V; Infectious Diseases Department, Karolinska University Hospital, Stockholm, Sweden.
Elinav H; Department of Clinical Microbiology and Infectious Diseases, Hadassah Hospital, Jerusalem, Israel.
Laguno M; Infectious Diseases Service, Hospital Clinic, Barcelona, Spain.
Mansinho K; Hospital de Egas Moniz, Lisbon, Portugal.
Devitt E; Department of Genitourinary Medicine and Infectious Diseases, St James's Hospital, Dublin, Ireland.
Chkhartishvili N; Infectious Diseases, AIDS & Clinical Immunology Research Center, Tbilisi, Georgia.
Behrens G; Medizinische Hochschule Hannover, Hannover, Germany.
Bogner J; Division of Infectious Diseases, Medizinische Klinik und Poliklinik IV, Ludwig Maximilian University of Munich, Munich, Germany.
Viard JP; Diagnostic and Therapeutic Center, Hôtel-Dieu, AP-HP, Paris, France.
Winston A; Department of Infectious Disease, Imperial College London, London, UK.
Benfield T; Department of Infectious Diseases, Hvidovre Hospital, Hvidovre, Denmark.
Leen C; Western General Hospital, Edinburgh, UK.
Fursa O; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Rockstroh J; Department of Medicine, University Hospital Bonn, Bonn, Germany.
Peters L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Pokaż więcej
Corporate Authors:: EuroSIDA study group
Źródło:: HIV medicine [HIV Med] 2023 Feb; Vol. 24 (2), pp. 224-230. Date of Electronic Publication: 2022 Aug 08.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/complications
HIV Infections*/drug therapy
Coinfection*/drug therapy
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/complications
Hepatitis C*/drug therapy
Acquired Immunodeficiency Syndrome*/drug therapy
Humans ; Male ; Middle Aged ; Female ; Antiviral Agents/therapeutic use ; Hepacivirus ; Anti-Retroviral Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis.
Autorzy:: Marquez LK; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, United States of America.
Ingiliz P; Center for Infectiology, Berlin, Germany.; Hepatology Department, Henri-Mondor Hospital, INSERM U955, Créteil, France.
Boesecke C; Department of Medicine, University of Bonn, Bonn, Germany.
Krznaric I; Center for Infectiology, Berlin, Germany.
Schewe K; ICH-Studycenter, Hamburg, Germany.
Lutz T; Infektiologikum, Frankfurt, Germany.
Mauss S; Center for HIV and Hepatogastroenterology, Duesseldorf, Germany.
Christensen S; CIM Münster, Münster, Germany.; Department of Gastroenterology and Hepatology, Muenster University Hospital, Muenster, Germany.
Rockstroh JK; Department of Medicine, University of Bonn, Bonn, Germany.
Jain S; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, United States of America.
He F; Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, United States of America.
Wertheim JO; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, United States of America.
Martin NK; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 May 12; Vol. 17 (5), pp. e0267853. Date of Electronic Publication: 2022 May 12 (Print Publication: 2022).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: COVID-19*/epidemiology
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C, Chronic*/drug therapy
Sexual and Gender Minorities*
Antiviral Agents/therapeutic use ; Germany/epidemiology ; Hepacivirus ; Homosexuality, Male ; Humans ; Incidence ; Male ; Pandemics ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Late presentation of chronic hepatitis C patients in the era of direct-acting antivirals-Data from the German Hepatitis C-Registry.
Autorzy:: Bischoff J; Department of Medicine I, University Hospital Bonn, Bonn, Germany.
Mauss S; Center for HIV and Hepatogastroenterology, Düsseldorf, Germany.
Lutz T; Infektiologikum, Frankfurt am Main, Germany.
Cordes C; Studiengesellschaft Warschauer 33 mbH, c/o Praxis Dr. Cordes, Berlin, Germany.
Klausen G; Schwerpunktpraxis für Infektionsmedizin, Berlin, Germany.
Scholten S; Dr. Scholten und Schneeweiß GbR, Cologne, Germany.
Hillenbrand H; Praxis City Ost, Berlin, Germany.
Cornberg M; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School (MHH), Hannover, Germany.; Centre for individualised infection Medicine (CiiM), Hannover, Germany.
Baumgarten A; Center for infectious diseases, Berlin, Germany.
Rockstroh JK; Department of Medicine I, University Hospital Bonn, Bonn, Germany.; Pokaż więcej
Corporate Authors:: German Hepatitis C-Registry; Leberstiftungs-GmbH Deutschland, Hannover, Germany.
Źródło:: Journal of viral hepatitis [J Viral Hepat] 2021 Nov; Vol. 28 (11), pp. 1660-1664. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Coinfection*/drug therapy
HIV Infections*/drug therapy
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Antiviral Agents/therapeutic use ; Hepacivirus ; Humans ; Registries

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men.
Autorzy:: Popping S; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Hullegie SJ; Department of Internal Medicine and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands.
Boerekamps A; Department of Internal Medicine and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands.
Rijnders BJA; Department of Internal Medicine and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands.
de Knegt RJ; Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands.
Rockstroh JK; Department of Internal Medicine, Bonn University Hospital, Bonn, Germany.
Verbon A; Department of Internal Medicine and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands.
Boucher CAB; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Nichols BE; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.; Department of Global Health, Boston University, Boston, United States.
van de Vijver DAMC; Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2019 Jan 10; Vol. 14 (1), pp. e0210179. Date of Electronic Publication: 2019 Jan 10 (Print Publication: 2019).
Typ publikacji:: Journal Article
MeSH Terms:: Cost-Benefit Analysis*
Antiviral Agents/*therapeutic use
HIV Infections/*complications
Hepatitis C/*drug therapy
Sexual and Gender Minorities/*statistics & numerical data
Adult ; Aged ; Aged, 80 and over ; Antiviral Agents/economics ; HIV Infections/mortality ; Health Care Costs/statistics & numerical data ; Hepacivirus/isolation & purification ; Hepatitis C/complications ; Hepatitis C/epidemiology ; Hepatitis C/transmission ; Humans ; Incidence ; Life Expectancy ; Male ; Middle Aged ; Models, Economic ; Netherlands/epidemiology ; Prevalence ; Quality-Adjusted Life Years ; Survival Rate ; Time Factors ; Time-to-Treatment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
Autorzy:: Grebely J; The Kirby Institute, UNSW Sydney, Sydney, Australia.; Executive Board, International Network on Hepatitis in Substance Users, Zurich, Switzerland.
Dore GJ; The Kirby Institute, UNSW Sydney, Sydney, Australia.; Executive Board, International Network on Hepatitis in Substance Users, Zurich, Switzerland.
Morin S; HIV Programmes and Advocacy, International AIDS Society, Geneva, Switzerland.
Rockstroh JK; Department of Medicine I, University Hospital Bonn, Bonn, Germany.; Governing Council, International AIDS Society, Geneva, Switzerland.
Klein MB; Governing Council, International AIDS Society, Geneva, Switzerland.; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Canada.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2017 Jul 28; Vol. 20 (1), pp. 22146.
Typ publikacji:: Journal Article
MeSH Terms:: Disease Eradication*
Hepatitis C/*prevention & control
Substance Abuse, Intravenous/*complications
Government Programs ; Harm Reduction ; Hepatitis C/epidemiology ; Hepatitis C/etiology ; Humans ; Incidence ; Opiate Substitution Treatment ; Public Health ; Substance Abuse, Intravenous/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Alterations of the NK cell pool in HIV/HCV co-infection.
Autorzy:: Kaczmarek DJ; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Kokordelis P; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Krämer B; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Glässner A; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Wolter F; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Goeser F; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Lutz P; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Schwarze-Zander C; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Boesecke C; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Strassburg CP; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Rockstroh JK; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Spengler U; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.
Nattermann J; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Bonn, Germany.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2017 Apr 05; Vol. 12 (4), pp. e0174465. Date of Electronic Publication: 2017 Apr 05 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: Coinfection/*immunology
HIV Infections/*complications
Hepatitis C/*complications
Killer Cells, Natural/*physiology
Adult ; Aged ; Case-Control Studies ; Coinfection/virology ; Cross-Sectional Studies ; Flow Cytometry ; HIV Infections/immunology ; Hepatitis C/immunology ; Humans ; Interferon-gamma/metabolism ; Lymphocyte Count ; Male ; Middle Aged ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.
Autorzy:: Lazarus JV; Jeffrey V Lazarus, CHIP, Rigshospitalet, University of Copenhagen, Oster Allé 56, 5th floor, DK-2100 Copenhagen O, Denmark, .
Sperle I
Spina A
Rockstroh JK; Pokaż więcej
Źródło:: Croatian medical journal [Croat Med J] 2016 Oct 31; Vol. 57 (5), pp. 442-456.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Hepatitis B/*diagnosis
Hepatitis C/*diagnosis
Europe/epidemiology ; Humans ; Male ; Mass Screening ; World Health Organization

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord.
Autorzy:: Smit C; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Arends J; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Peters L; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Montforte Ad; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Dabis F; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Zangerle R; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Daikos G; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Mussini C; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Mallolas J; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
de Wit S; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. stephane_.
Zinkernagel A; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Cosin J; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Chene G; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Raben D; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. .
Rockstroh J; Stichting HIV Monitoring, Meibergdreef 9, 1105AZ, Amsterdam, The Netherlands. Juergen.Rockstroh@ukb.uni-bonn.de.; Pokaż więcej
Corporate Authors:: Hepatitis C- working group for COHERE in Eurocoord
Źródło:: BMC infectious diseases [BMC Infect Dis] 2015 Nov 04; Vol. 15, pp. 498. Date of Electronic Publication: 2015 Nov 04.
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Dideoxynucleosides/*therapeutic use
HIV Infections/*drug therapy
Hepatitis C/*drug therapy
Adult ; Anti-HIV Agents/therapeutic use ; Cohort Studies ; Coinfection/drug therapy ; Drug Combinations ; Emtricitabine/therapeutic use ; Europe ; Female ; Hepacivirus/drug effects ; Hepacivirus/genetics ; Humans ; Interferon-alpha/therapeutic use ; Lamivudine/therapeutic use ; Male ; Middle Aged ; Polyethylene Glycols/therapeutic use ; Recombinant Proteins/therapeutic use ; Reverse Transcriptase Inhibitors/therapeutic use ; Ribavirin/therapeutic use ; Tenofovir/therapeutic use ; Zidovudine/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?
Autorzy:: Boesecke C; Department of Internal Medicine I, Bonn University Hospital, Bonn, Germany.
Grint D; UCL, London, UK.
Soriano V; Hospital Carlos III, Madrid, Spain.
Lundgren JD; Department of Infectious Diseases and Rheumatology, CHIP, Rigshospitalet, Copenhagen, Denmark.
d'Arminio Monforte A; Istituto Di Clinica Malattie Infettive e Tropicale, Milan, Italy.
Mitsura VM; Gomel State Medical University, Gomel, Belarus.
Chentsova N; Kiev Centre for AIDS, Kiev, Ukraine.
Hadziosmanovic V; Klinicki Centar Univerziteta Sarajevo, Sarajevo, Bosnia-Herzegovina.
Kirk O; Department of Infectious Diseases and Rheumatology, CHIP, Rigshospitalet, Copenhagen, Denmark.
Mocroft A; UCL, London, UK.
Peters L; Department of Infectious Diseases and Rheumatology, CHIP, Rigshospitalet, Copenhagen, Denmark.
Rockstroh JK; Department of Internal Medicine I, Bonn University Hospital, Bonn, Germany.; Pokaż więcej
Corporate Authors:: EuroSIDA in EuroCoord
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2015 Nov; Vol. 35 (11), pp. 2384-91. Date of Electronic Publication: 2015 Apr 29.
Typ publikacji:: Journal Article; Multicenter Study; Observational Study
MeSH Terms:: Seroconversion*
HIV Infections/*complications
Hepatitis C/*epidemiology
Hepatitis C Antibodies/*blood
Adult ; Disease Outbreaks ; Drug Users ; Europe ; Female ; Hepacivirus ; Homosexuality, Male ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
Autorzy:: Dold L; Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany; German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany.
Ahlenstiel G; Westmead Clinical School, University of Sydney, Sydney, Australia.
Althausen E; Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany; German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany.
Luda C; Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany; German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany.
Schwarze-Zander C; Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany; German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany.
Boesecke C; Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany; German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany.
Wasmuth JC; Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany; German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany.
Rockstroh JK; Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany; German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany.
Spengler U; Department of Internal Medicine 1, Rheinische Friedrich-Wilhelms University Bonn, Bonn, Germany; German Centre of Infection Research (DZIF), partner site Cologne-Bonn, Germany.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Aug 04; Vol. 10 (8), pp. e0134158. Date of Electronic Publication: 2015 Aug 04 (Print Publication: 2015).
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiretroviral Therapy, Highly Active*
Coinfection/*mortality
HIV Infections/*mortality
HLA-B Antigens/*analysis
Hepatitis C/*mortality
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alleles ; Anti-HIV Agents/therapeutic use ; CD4 Lymphocyte Count ; Coinfection/immunology ; Disease Progression ; Follow-Up Studies ; Gene Frequency ; Genes, MHC Class I ; Genes, MHC Class II ; Genotype ; HIV Infections/complications ; HIV Infections/drug therapy ; HIV Infections/immunology ; HLA-A Antigens/analysis ; HLA-B Antigens/genetics ; Hepatitis C/complications ; Hepatitis C/drug therapy ; Hepatitis C/immunology ; Humans ; Hyperbilirubinemia/etiology ; Kaplan-Meier Estimate ; Middle Aged ; Proportional Hazards Models ; Prospective Studies ; T-Lymphocytes, Cytotoxic/immunology ; Viral Load ; Young Adult ; gamma-Glutamyltransferase/blood

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection.
Autorzy:: Jansen C; Department of Internal Medicine I, University of Bonn, Bonn, Germany.
Reiberger T; Department of Internal Medicine III, Division of Gastroenterology & Hepatology, Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
Huang J; Department of Pathology, University of Cologne, Cologne, Germany.
Eischeid H; Department of Pathology, University of Cologne, Cologne, Germany.
Schierwagen R; Department of Internal Medicine I, University of Bonn, Bonn, Germany.
Mandorfer M; Department of Internal Medicine III, Division of Gastroenterology & Hepatology, Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
Anadol E; Department of Internal Medicine I, University of Bonn, Bonn, Germany.
Schwabl P; Department of Internal Medicine III, Division of Gastroenterology & Hepatology, Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
Schwarze-Zander C; Department of Internal Medicine I, University of Bonn, Bonn, Germany.
Warnecke-Eberz U; Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany.
Strassburg CP; Department of Internal Medicine I, University of Bonn, Bonn, Germany.
Rockstroh JK; Department of Internal Medicine I, University of Bonn, Bonn, Germany; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Peck-Radosavljevic M; Department of Internal Medicine III, Division of Gastroenterology & Hepatology, Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
Odenthal M; Department of Pathology, University of Cologne, Cologne, Germany.
Trebicka J; Department of Internal Medicine I, University of Bonn, Bonn, Germany.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Feb 03; Vol. 10 (2), pp. e0116768. Date of Electronic Publication: 2015 Feb 03 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Coinfection/*complications
HIV Infections/*complications
Hepatitis C/*complications
Hypertension, Portal/*blood
Liver Cirrhosis/*blood
MicroRNAs/*blood
Adult ; Female ; Humans ; Hypertension, Portal/complications ; Hypertension, Portal/physiopathology ; Liver/injuries ; Liver Cirrhosis/complications ; Liver Cirrhosis/physiopathology ; Male ; Middle Aged ; Portal Pressure ; Retrospective Studies ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
Autorzy:: Rockstroh JK; Department of Internal Medicine I, Bonn University Hospital, Bonn, Germany; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.; Pokaż więcej
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2015 Jan; Vol. 35 Suppl 1, pp. 51-5.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Antiviral Agents/*therapeutic use
Coinfection/*drug therapy
Drug Interactions/*physiology
Drug Therapy, Combination/*methods
HIV Infections/*drug therapy
Hepacivirus/*drug effects
Hepatitis C/*drug therapy
Drug Therapy, Combination/trends ; Genotype ; Hepacivirus/genetics ; Humans ; Patient Selection

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Managing HIV/hepatitis C co-infection in the era of direct acting antivirals.
Autorzy:: Rockstroh JK; Department of Medicine I, University Hospital Bonn, Sigmund-Freud-Str, 25, 53105 Bonn, Germany. juergen.rockstroh@ukb.uni-bonn.de.
Bhagani S; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2013 Nov 01; Vol. 11, pp. 234. Date of Electronic Publication: 2013 Nov 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Antiviral Agents/*therapeutic use
Coinfection/*drug therapy
Coinfection/*virology
HIV Infections/*drug therapy
HIV Infections/*virology
Hepatitis C/*drug therapy
Hepatitis C/*virology
Humans ; Interferons/therapeutic use ; Ribavirin/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study.
Autorzy:: Schmidt AJ; Department for Infectious Diseases Epidemiology, Robert Koch Institute, Berlin, Germany. />Rockstroh JK
Vogel M
An der Heiden M
Baillot A
Krznaric I
Radun D; Pokaż więcej
Źródło:: PloS one [PLoS One] 2011 Mar 08; Vol. 6 (3), pp. e17781. Date of Electronic Publication: 2011 Mar 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: HIV Seropositivity/*complications
Hemorrhage/*complications
Hepatitis C/*complications
Hepatitis C/*epidemiology
Homosexuality, Male/*statistics & numerical data
Acute Disease ; Adult ; Aged ; Case-Control Studies ; Condoms ; Cross Infection/complications ; Demography ; Germany/epidemiology ; Health Knowledge, Attitudes, Practice ; Humans ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Risk Factors ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany.
Autorzy:: Vogel M; Department of Internal Medicine I, University of Bonn, Bonn, Germany. />van de Laar T
Kupfer B
Stellbrink HJ
Kümmerle T
Mauss S
Knecht G
Berger A
Bruisten S
Rockstroh JK; Pokaż więcej
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2010 Sep; Vol. 30 (8), pp. 1169-72. Date of Electronic Publication: 2010 Jul 12.
Typ publikacji:: Journal Article
MeSH Terms:: Homosexuality, Male*
Phylogeny*
HIV Infections/*complications
Hepacivirus/*genetics
Hepatitis C/*complications
Hepatitis C/*epidemiology
Hepatitis C/*virology
Adult ; Base Sequence ; Computational Biology ; Germany/epidemiology ; Humans ; Likelihood Functions ; Male ; Middle Aged ; Models, Genetic ; Molecular Sequence Data ; Sequence Analysis, DNA ; Viral Nonstructural Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: The way forward in HCV treatment--finding the right path.
Autorzy:: Manns MP; Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Hannover, Germany. />Foster GR
Rockstroh JK
Zeuzem S
Zoulim F
Houghton M; Pokaż więcej
Źródło:: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2007 Dec; Vol. 6 (12), pp. 991-1000.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Antiviral Agents/*therapeutic use
Hepatitis C/*drug therapy
Hepacivirus/physiology ; Hepatitis C/physiopathology ; Hepatitis C Antibodies/analysis ; Humans ; Virus Replication